AI accelerates hunt for new antibiotics as gram-negative resistance grows

Roche research highlights that no new antibiotic class for gram-negative bacteria has been introduced since the late 1960s, while resistance to existing drugs continues to rise. AI is being applied to accelerate discovery of novel compounds, though no breakthrough candidate is named. This underscores a critical public-health gap and the potential of AI-driven drug discovery.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works